Exenatide sustained release

N/A

Report date: 2025/12/19 20:01:35

Base Information

Drug NameExenatide sustained release
Drug Alias NameSR exenatide - PeptronExenatide sustained-releaseExenatide sustained-release - Peptron/Yuhan CorporationP302PT-304 +[9] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes MellitusPseudotumor Cerebri +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia +[7] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYuhan CorpPeptron Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvex Therapeutics LtdPeptron IncYuhan Corp
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes MellitusPseudotumor Cerebri +[4] 

Other Information

ATC CodeN/A
Related LinksN/A